Caligan Partners LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$763.5B
Holdings
17
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 8,118,892 | $184.6B | 24.18% | |
| 2 | ABVXABIVAX SA | 1,451,924 | $123.3B | 16.14% | |
| 3 | MLYSMINERALYS THERAPEUTICS INC | 2,772,654 | $105.1B | 13.77% | |
| 4 | AGIOAGIOS PHARMACEUTICALS INC | 2,106,205 | $84.5B | 11.07% | Put |
| 5 | EX9EXELIXIS INC | 1,525,730 | $63.0B | 8.25% | |
| 6 | RVMDREVOLUTION MEDICINES INC | 1,064,249 | $49.7B | 6.51% | |
| 7 | ADMAADMA BIOLOGICS INC | 2,636,609 | $38.7B | 5.06% | |
| 8 | EOLSEVOLUS INC | 4,138,943 | $25.4B | 3.33% | |
| 9 | MRUSMERUS N V | 216,954 | $20.4B | 2.68% | |
| 10 | XENEXENON PHARMACEUTICALS INC | 444,565 | $17.8B | 2.34% | |
| 11 | ANIKANIKA THERAPEUTICS INC | 1,435,130 | $13.5B | 1.77% | |
| 12 | AVTXAVALO THERAPEUTICS INC | 833,333 | $10.6B | 1.39% | |
| 13 | TYRATYRA BIOSCIENCES INC | 696,825 | $9.7B | 1.28% | |
| 14 | INBXINHIBRX BIOSCIENCES INC | 236,383 | $8.0B | 1.04% | |
| 15 | VRCAVERRICA PHARMACEUTICALS INC | 923,910 | $4.0B | 0.52% | |
| 16 | SLSSELLAS LIFE SCIENCES GROUP I | 2,300,000 | $3.7B | 0.48% | Call |
| 17 | AURAAURA BIOSCIENCES INC | 227,174 | $1.4B | 0.18% |